Brief: Alligator Bioscience Q2 EBIT Loss at SEK 63.7 Million
13/07/2023 07:02
Jul 13 (Reuters) - Alligator Bioscience Q2 adjusted EPS SEK -0.19. * Q2 revenue SEK 17.4 million * Q2 EBIT SEK -63.7 million * Q2 net income SEK -63.7 million
Recent news on Alligator Bioscience AB
See all newsBrief: Alligator Bioscience Q1 Net Loss SEK 1.4 Million
Sweden's Alligator Bioscience posts Q1 net profit, narrows operating loss
Brief: Alligator Bioscience Q1 EBIT SEK -17.8 Million
Brief: Alligator Bioscience Signs LoI With Unicancer For Phase 3 Mitazalimab Development
Brief: Exercise Of Warrants Brings Alligator Bioscience Net Proceeds Of SEK 12 Mln